TY - JOUR
T1 - Surface antigens as virulence factors in infection with bacteroides fragilis
AU - Kasper, Dennis L.
AU - Onderdonk, Andrew B.
AU - Polk, B. Frank
AU - Bartlett, John G.
N1 - Funding Information:
The virulence properties of bacteria have been attributed to a number of substances that appear to help the organism invade tissues. Although many bacteria elaborate virulence-enhancing substances, such as enzymes and toxins, in others the pathogenic properties are structurally integrated into the cell wall. For example, the virulence of bacteria that behave as extracellular parasites is often caused, at least in part, by antiphagocytic polysaccharide capsules that form a gel-like matrix around the cell. When the Streptococcus pneumoniae was studied in mice, it was found that unencapsulated strains were virtually This work wassupported by contracts no. DAMD-17-78C-8019 and DAMD-17-74C-4056 from the U.S. Army Medical Research and Development Command. Dr. Kasper is the recipient of Research Career Development Award 1 K04AI 00126 from the National Institute of Allergy and Infectious Diseases.
Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 1979/3
Y1 - 1979/3
N2 - Organisms of the genus Bacteroides represent the major group of obligate anaerobes involved in human infections. Bacteroides usually cause either bacteremia or localized abscesses. Of the numerous species of Bacteroides, Bacteroides fragilis is the single most frequent clinical isolate. B. fragilis and Bacteroides melaninogenicus have chemically incomplete lipopolysaccharides as compared with the lipopolysac- charides (endotoxins) of aerobic bacteria, and the lipopolysaccharides of Bacteroides lack the biologic potency characteristic of endotoxin. This inactivity may account for the very infrequent occurrence of disseminated intravascular coagulation or purpura that can accompany sepsis due to these organisms. Furthermore, strains of B. fragilis have an immunologically common capsular polysaccharide. In an animal model of intraabdominal sepsis, the encapsulated strains caused abscesses when given without other organisms, but abscess formation from unencapsulated strains of Bacteroides generally required the administration of a synergistic aerobe. The abscesses caused by encapsulated strains were shown to be directly attributable to the capsular polysaccharide, which is an important virulence factor of this organism. Patients or experimental animals infected with B. fragilis develop antibodies to the capsular polysaccharide, and these antibodies can be detected in a radioactive antigen-binding assay.
AB - Organisms of the genus Bacteroides represent the major group of obligate anaerobes involved in human infections. Bacteroides usually cause either bacteremia or localized abscesses. Of the numerous species of Bacteroides, Bacteroides fragilis is the single most frequent clinical isolate. B. fragilis and Bacteroides melaninogenicus have chemically incomplete lipopolysaccharides as compared with the lipopolysac- charides (endotoxins) of aerobic bacteria, and the lipopolysaccharides of Bacteroides lack the biologic potency characteristic of endotoxin. This inactivity may account for the very infrequent occurrence of disseminated intravascular coagulation or purpura that can accompany sepsis due to these organisms. Furthermore, strains of B. fragilis have an immunologically common capsular polysaccharide. In an animal model of intraabdominal sepsis, the encapsulated strains caused abscesses when given without other organisms, but abscess formation from unencapsulated strains of Bacteroides generally required the administration of a synergistic aerobe. The abscesses caused by encapsulated strains were shown to be directly attributable to the capsular polysaccharide, which is an important virulence factor of this organism. Patients or experimental animals infected with B. fragilis develop antibodies to the capsular polysaccharide, and these antibodies can be detected in a radioactive antigen-binding assay.
UR - http://www.scopus.com/inward/record.url?scp=0018440081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018440081&partnerID=8YFLogxK
U2 - 10.1093/clinids/1.2.278
DO - 10.1093/clinids/1.2.278
M3 - Article
C2 - 549184
AN - SCOPUS:0018440081
SN - 1058-4838
VL - 1
SP - 278
EP - 290
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 2
ER -